Hsp90 Inhibitors and the Reduction of Anti-Cancer Drug Resistance by Non-Genetic and Genetic Mechanisms

Author： Lu Xiangyi   Wang Luan   Ruden Douglas M.  

Publisher： MDPI

E-ISSN： 1424-8247|5|9|890-898

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.5, Iss.9, 2012-08, pp. : 890-898

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanisms of Resistance to Hsp90 Inhibitor Drugs: A Complex Mosaic Emerges

By Piper Peter W.   Millson Stefan H.  

Pharmaceuticals, Vol. 4, Iss. 11, 2011-10 ,pp. : 1400-1422

MDPI

Access to resources Recommend Favorite

Non-Invasive Methods to Monitor Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer: Where Do We Stand?

By Ulivi Paola  

International Journal of Molecular Sciences, Vol. 17, Iss. 7, 2016-07 ,pp. : 1186-1186

MDPI

Access to resources Recommend Favorite

Heat Shock Protein 90 (Hsp90) Expression and Breast Cancer

By Zagouri Flora   Bournakis Evangelos   Koutsoukos Konstantinos   Papadimitriou Christos A.  

Pharmaceuticals, Vol. 5, Iss. 9, 2012-09 ,pp. : 1008-1020

MDPI

Access to resources Recommend Favorite

Gender Differences in the VDR-FokI Polymorphism and Conventional Non-Genetic Risk Factors in Association with Lumbar Spine Pathologies in an Italian Case-Control Study

By Colombini Alessandra   Brayda-Bruno Marco   Ferino Lucia   Lombardi Giovanni   Maione Vincenzo   Banfi Giuseppe   Cauci Sabina  

International Journal of Molecular Sciences, Vol. 16, Iss. 2, 2015-02 ,pp. : 3722-3739

MDPI

Access to resources Recommend Favorite

Fucoxanthin: A Marine Carotenoid Exerting Anti-Cancer Effects by Affecting Multiple Mechanisms

By Kumar Sangeetha Ravi   Hosokawa Masashi   Miyashita Kazuo  

Marine Drugs, Vol. 11, Iss. 12, 2013-12 ,pp. : 5130-5147

MDPI

Access to resources Recommend Favorite